Michael Parks, MD
Orthopaedic Surgery · New York, NYNPI 1992762587
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $65,250 of the $75,344 with a category attached, or 86.6%. Zimmer Biomet accounts for 96.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $37,093 and has fallen 100.0% since, to $19 in 2025.
Across 100 payments — averaging $753.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$73K
- Smith+Nephew$2K
- Orthalign Inc$148
- Siemens Medical Solutions USA, Inc.$66
- Overture Orthopaedics$19
Across 2 payments — averaging $30,750 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$62K
Across 1 payment — averaging $4168.64 each. An ownership or investment interest held by the physician or an immediate family member.
- Overture Orthopaedics$4K
What the payments were for
- Consulting fees$65,25087%
- Travel & lodging$7,73410%
- Food & beverage$2,2533%
- Education$170%
- Gifts$710%
- Entertainment$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 90 | $72,992 |
| Smith+Nephew | 7 | $2,120 |
| Orthalign Inc | 1 | $148 |
| Siemens Medical Solutions USA, Inc. | 1 | $66 |
| Overture Orthopaedics | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hips-None$25,393
- ACA Screw Cup$9,500
- Absolute Bi-Polar Shoulder$9,250
- Knees Product Portfolio$6,229
- Journey II$2,676
- Surgical Product Portfolio$2,501
- Legion Revision$1,151
- OR3O Dual Mobility$1,151
- RI.HIP NAVIGATION$1,151
- JOURNEY$1,151
- Minority Initiatives-None$1,034
- Persona$850
- Oxford$512
- Persona Revision$500
- Surgical-None$480
- ORTHALIGN PLUS$148
How this compares
$75,344 in reported general payments places this provider in the 85th percentile of 1,079 orthopaedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 12 | $63 |
| Oxycodone Hcl | 12 | $40 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New York
- Anthony RomeoNew York$26.8M
- Lawrence LenkeNew York$26.8M
- Edwin SuNew York$13.2M
- William RicciNew York$11.6M
- Steven HaasNew York$11.3M
- Giles ScuderiNew York$10.7M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
- Geoffrey WestrichNew York$7.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.